Core Laboratories (CLB) Long-Term Deferred Tax (2022 - 2025)
Core Laboratories' Long-Term Deferred Tax history spans 4 years, with the latest figure at $67.4 million for Q4 2025.
- For Q4 2025, Long-Term Deferred Tax fell 3.21% year-over-year to $67.4 million; the TTM value through Dec 2025 reached $67.4 million, down 3.21%, while the annual FY2025 figure was $67.4 million, 3.21% down from the prior year.
- Long-Term Deferred Tax reached $67.4 million in Q4 2025 per CLB's latest filing, down from $70.5 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $72.3 million in Q3 2023 to a low of $66.3 million in Q1 2024.
- Average Long-Term Deferred Tax over 4 years is $69.3 million, with a median of $69.4 million recorded in 2023.
- The largest YoY upside for Long-Term Deferred Tax was 2.56% in 2024 against a maximum downside of 3.29% in 2024.
- A 4-year view of Long-Term Deferred Tax shows it stood at $68.6 million in 2022, then rose by 0.92% to $69.2 million in 2023, then grew by 0.6% to $69.6 million in 2024, then dropped by 3.21% to $67.4 million in 2025.
- Per Business Quant, the three most recent readings for CLB's Long-Term Deferred Tax are $67.4 million (Q4 2025), $70.5 million (Q3 2025), and $70.5 million (Q2 2025).